Endometriosis is the hormone-dependent product of endometrial tissue found outside the uterus. Recently, micro-RNAs (miRNAs) were shown to play a role in endometriotic lesion development. However, the mechanism of steroid hormones responsible for miRNA remains obscure. In the present study, we assayed for the effects of synthetic steroid hormones (danazol, progesterone, and medroxyprogesterone acetate [MPA]) on miRNAs in endometriosis. We used a global miRNA expression profile microarray to evaluate miRNA expression in endometrial mesenchymal stem cells (EN-MSCs) of ovarian endometrioma following treatment with 1 lM danazol, progesterone, or MPA. Furthermore, we selected candidate miRNAs whose expression changed more than fivefold and compared the effects of danazol, progesterone, and MPA treatments and also compared those results with controls in EN-MSCs. Among those with a fivefold change, we found 13 ectopically upregulated miRNAs in EN-MSCs. To understand the function of these 13 miRNAs, we subjected their sequences to Ingenuity Pathway Analysis. According to both the etiology and pathogenesis of endometriosis, we found that miR-199a-5p and miR-34a-5p showed specific association with the disease, including molecular and cellular functions. Steroid hormone treatment elevated the levels of miR-199a-5p and miR-34a-5p. An inhibitor of miR-34a-5p also reduced the synthetic steroid hormones effects on cell proliferation. In vivo data revealed that miRNA levels in endometriotic lesions correlated with findings following in vitro synthetic hormone treatment. Our data show the effects of synthetic steroid hormones on miRNA regulation. These findings contribute to our understanding of the molecular impact of the synthetic steroid hormones and suggest a potential mechanism for endometriosis treatment.
INTRODUCTION
Endometriosis, defined as the presence of endometriallike tissue outside the uterus, is a common estrogen-dependent gynecological disorder with a complex, multifactorial etiology that affects approximately 10%-15% of women of reproductive age. Several theories explaining endometriosis pathogenesis have been proposed, including the widely accepted theory of retrograde transplantation and subsequent implantation of endometrial tissue fragments into ectopic locations after retrograde menstruation [1] . The theories of coelomic metaplasia, lymphovascular metastasis, embryonic rest, and stem cell involvement may also potentially explain the development of endometriosis [2, 3] . However, endometriosis is an enigmatic disease with unsolved pathogenesis. Recently, there is growing evidence indicating that stem cells act as the root etiology of endometriosis [2, [4] [5] [6] [7] . This theory postulates that endometriotic lesions result from endometrial stem/progenitor cells [2] . The human endometrium is a dynamic tissue, undergoing cycles of growth, differentiation, shedding, and regeneration, throughout a woman's reproductive years. Therefore, endometrial stem/progenitor cells are thought to have regenerative capacity. Owing to these regenerative traits, endometrial stem/progenitor cells may actually contribute to endometriosis formation. In our previous study, we demonstrated the presence of mesenchymal stem cells (MSCs) in stromal cells of ectopic endometrial tissues and established MSCs from patients with endometriosis. The results of the study showed that ectopic endometrial MSCs (EN-MSCs) have higher cell invasion ability in vitro and in vivo [8] . In addition, we also demonstrated that ectopic EN-MSCs application in the nude mice can form the endometrioticlike lesion [9] . Therefore, we used the ectopic EN-MSCs as the model for the study of endometriosis and to investigate the effect of the synthetic steroid hormone.
In addition, endometriosis is a multifactorial disease caused by hormonal milieu [10] , genetic predisposition [11, 12] , and environmental factors [13] . The high incidence of recurrence following treatment illustrates that the established theories may not fully explain the etiology of endometriosis. Implanted ectopic endometrial tissue can resist apoptosis [14, 15] , invade the extracellular matrix [16] , induce neovascularization [17] , and acquire steroidogenic capacity [18] .
Steroid hormones are produced in the ovaries, and they regulate the growth of endometrial tissue by stimulating or inhibiting cell proliferation. Steroid hormones play a role in uterine diseases such as endometriosis. Disruption of steroid hormone control of endometrial cell proliferation and differentiation can lead to endometriosis. Furthermore, implantation and maintenance of endometrial lesions are estrogen dependent.
Therefore, a variety of synthetic hormones, such as danazol, progesterone, and medroxyprogesterone acetate (MPA) have been contrived for the treatment of endometriosis [19] [20] [21] . They have been widely used in clinical therapy. These drugs act as a progestin or an androgenlike hormone inhibiting both ovarian estrogen production and the pituitary-based surge of luteinizing hormone. However, steroid-related molecular mechanisms-especially those related to micro-RNA (miRNA) regulation in endometriosis-are not well known.
The miRNAs are short (;19-22 nucleotides), highly conserved, noncoding RNAs that control gene expression by targeting a specific sequence within the 3 0 untranslated region of mRNAs, resulting in mRNA degradation or repression of translation. The miRNAs have been implicated in the regulation of cellular functions such as cell cycle progression [22] , proliferation [22] [23] [24] [25] , apoptosis [26, 27] , cell motility [28] , and angiogenesis [9] . Therefore, aberrant miRNA expression correlates with various human diseases, including hepatocarcinoma [29] , endometriosis [9, 30] , and others. In addition, a number of miRNAs are involved in the hormonal regulation of steroidogenic cells [31] . Here, we report our investigation of whether synthetic steroid hormones, by regulating the expression of certain miRNAs, modulate the function of EN-MSCs.
MATERIALS AND METHODS

Cell Culture
This study was approved by the Institutional Review Board of Kaohsiung Medical University Hospital. Participants provided their written informed consent (KMUH-IRB-20140031) to participate in this study. Ovarian endometrial tissue was obtained from women who received operations for indications of endometriosis at the Department of Obstetrics and Gynecology of Kaohsiung Medical University Hospital. We previously reported the procedures we used to isolate EN-MSCs from ovarian endometrial tissue [8] . Briefly, the tissues were minced with sterile scissors and digested with type II collagenase. Then, stromal cells were separated from epithelial cells using wire sieves. To isolate EN-MSCs, large colonies of stromal cells were selected and processed via limiting dilution, and colony formation potential was subsequently assessed. The EN-MSCs were characterized using MSC phenotypes, differentiation induction (i.e., adipogenesis, osteogenesis, chondrogenesis) and gene expression (i.e., OCT4, CD29, CD44, CD49f, CD90, Musashi-1, CD146, PDGF-Rb, and CD105) by flow cytometric analysis (Supplemental Materials and Methods; Supplemental Data are available online at www.biolreprod.org). For differentiation assays, EN-MSCs were seeded at 5 3 10 4 cells per well in a six-well plate, and on the next day, differentiation conditions were applied to the EN-MSCs as follows. Adipogenic differentiation of EN-MSCs was induced by treatment with 500 lM 3-isobutyl-1-methylxanthine, 1 lM dexamethasone, 1 lM indomethacin, and 10 lg/ml insulin for 2 days and insulin for 1 day. After four cycles of treatment for 12 days, these cells were fixed with 4% paraformaldehyde (Sigma-Aldrich) and stained using Oil Red O staining of the lipid droplets. For osteogenesis differentiation, 10 nM dexamethasone, 50 lM L-ascorbic acid-2-phosphate (Asc-2P) and 10 mM b-glycerophosphate disodium were added to the growth medium for 2 wk with medium change and treatment renewed once every 3 days; the cells were then stained with Alizarin Red S to visualize the calcium 14 days after the initiation of differentiation for the existence of osteocytes. Chondrogenesis differentiation of EN-MSCs was induced by treatment with 10 ng/ml TGF-b1, 50 lM Asc-2P, and 6.25 lg/ml insulin; the medium was changed every 3 days. After 14 days, the micromass were fixed in 4% paraformaldehyde and then examined for the presence of chondrocytes by Alcian Blue 8-Gx staining of the extracellular matrix. The expression of adipogenic, osteogenic, and chondrogenic markers, FABP4, Runx2, and collagen II, respectively, were determined by quantitative RT-PCR (qPCR).
According to our previous reports [8] , we collected the total population (which contains epithelium and stromal cells of ovarian endometrioma) after passing through 70 lm wire sieves. Then, passing through a 40 lm strainer (which contains stromal cells), we purified MSCs from endometriotic stromal cells after limiting dilution and colony formation. We collected MSCs from the large colony formation after identification. Those without large colony formation are defined as non-MSCs. Eventually, three EN-MSC cultures were obtained by this process. EN-MSCs were cultured in Dulbecco modified Eagle medium: Nutrient Mixture F12 (Gibco-Life Technologies) and MCDB 153 medium (Keratinocyte-SFM; Gibco-Life Technologies) (2:1, v/v) supplemented with 10% fetal bovine serum (Gibco-Life Technologies), 2 mM N-acetyl-Lcysteine (Sigma-Aldrich), and 0.2 mM Asc-2P (Sigma-Aldrich). EN-MSCs were incubated at 378C under humidified atmosphere with 5% CO 2 .
Chemicals and Reagents
Danazol, progesterone, MPA, and b-estradiol were purchased from SigmaAldrich. Primers were commercially synthesized at Genemessenger Scientific Co. The primers used in this study were the following: 18S, 0 (antisense). The qPCR primer sequences for miR-199a-5p and miR-34a-5p were as follows: Stem loop primer for miR-199a-5p, GCCAACCCAGUGUU-CAGACUACCUGUU CAGGAGGCUCUCAAUGUGUACAGUAGUCUG CACAUUGGUUAGGC; Stem loop primer for miR-34a-5p, GGCCAGCU GUGAGUGUUUCUUUGG CAGUGUCUUAGCUGGUUGUUGUGAG CAAUAGUAAGGAAGCAAUCAGCAAGUAUACUGCCCUAGAAGUG CUGCACGUUGUGGGGCCC (Applied Biosystems).
Cell Viability Assay
Cells were seeded into 96-well plates at 5000 cells/well and incubated at 378C in 5% CO 2 . The cells were changed to serum-free medium the following day and left to acclimatize for 24 h prior to the experiment. After 24 h, the cells were treated with synthetic steroid hormones and transfected with a specific miRNA inhibitor, MH11030. Viable cells were counted using the 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2, 4-disulfophenyl)-2H-tetrazolium monosodium salt (WST-8) assay. The WST-8 assay was performed using Cell Counting Kit-8 (Fluka Chemika-Biochemika). To begin, 90 ll of culture medium and 10 ll of Cell Counting Kit-8 reagent were added to each well. Cell viability was assayed after 2 h using an enzyme-linked immunosorbent assay reader (Multiskan EX; Labsystems) at 450 nm (reference, 650 nm). In each case, three independent experiments were performed.
RNA Extraction and qPCR
To assess miRNA and mRNA expression, total RNA was isolated from ENMSCs and endometriotic lesions from mice using TRIzol (Sigma-Aldrich). For qPCR, reverse transcription was carried out using the Deoxyþ HiSpec Reverse Transcription kit (Yeastern) and TaqMan Micro-RNA Reverse Transcription kit (Applied Biosystems). Subsequent qPCR was performed using an ABI 7900 Real-Time PCR system (Applied Biosystems).
The product was amplified using the Power SYBR Green PCR Master Mix (Applied Biosystems). Mature miRNA expression levels were measured using the TaqMan Micro-RNA Assay (Applied Biosystems). Expression levels were normalized to that of 18S mRNA, an endogenous control. Relative miRNA expression was calculated using the 2 À44Ct method.
Expression Profiles and Quantification of miRNA
Total RNA (3 lg) from EN-MSCs was reverse transcribed using the QuantiMir RT kit (System Biosciences). Expression profiling of miRNA was performed using the SeraMir 384 Profile kit (System Biosciences). The array consisted of 380 antisense miRNA oligonucleotide primers and triplicate HSU ET AL.
reactions for the RNA spike-in control in the kit. The miRNA expression profiles were measured by qPCR. Samples from three independent experiments were analyzed.
The comparative threshold cycle (Ct) method was used to quantify the expression levels where 4Ct represents the threshold cycle of the target minus that of the spike-in control and 44Ct represents the 4Ct of each target minus that of the calibrator. Fold changes in expression from treated samples to untreated samples were calculated with the 2 (ÀDDCt) method.
Functional Analysis of miRNA Target Genes
We applied the Ingenuity Pathway Analysis (IPA) (Ingenuity Systems) tool for canonical pathways and participating networks analysis of the hormoneinduced miRNA target genes.
Transfection
The miR-34a-5p inhibitor or a negative control was transfected into ENMSCs using Trans-IT-LT1 Transfection Reagent (Mirus Bio). The mirVana miRNA inhibitor (MH11030) and scramble control (4464078) were purchased from Ambion/Life Technologies. After 24 h of transfection, the cells were cultured in fresh medium. All cells achieved about 70%-80% of transfection efficiencies before being subjected to the assays described.
Western Blot Analysis
EN-MSCs were lysed using RIPA reagent (Millipore) supplemented with several protease and phosphatase inhibitors (G-Biosciences). Protein concentration was determined using the Bio-Rad protein assay method (Bio-Rad). Proteins were separated by 10% SDS-PAGE and transferred onto a polyvinylidene fluoride membrane. After blocking with 5% nonfat milk in PBS with 0.1% Tween for 1 h, the membranes were incubated with primary antibodies dissolved in 5% bovine serum albumin in PBS with 0.1% Tween overnight at 48C. The following primary antibodies were used: NOTCH1 (1:1000, 4380; Cell Signaling), PGRA/B (1:800, 8757; Cell Signaling), ESR1 (1:1000, sc-8002; Santa Cruz Biotechnology), or ACTIN (1:5000; SigmaAldrich). Horseradish peroxidase-conjugated secondary antibodies (Santa Cruz Biotechnology) and ECL reagents (Millipore) were used to detect the signal.
Animal Experiments
All procedures were performed in accordance with the Guidelines of the Institutional Animal Care and Use Committee of Kaohsiung Medical University Hospital. The protocol was approved by the Institutional Animal Care and Use Committee of Kaohsiung Medical University Hospital. Mature (8-to 10-wk-old) female C57BL/6NCrj mice were purchased from the National Laboratory Animal Centre (Taipei, Taiwan). Endometriosis was surgically induced as described [9, 32] . Briefly, to increase the amount of endometrium harvested, the donor mice were implanted subcutaneously with capsules containing 17b-estradiol (25 mg/ml dissolved in sesame oil) for 2 days, and their uterine horn were removed. For the implanted capsule surgery, mice were anesthetized with isoflurane in combination with carprofen. Carprofen (5 mg/ kg body weight) was injected subcutaneously before the surgery.
The uterine horns were removed, and endometrial fragments were obtained by peeling off the serosa and myometrium gently. Endometrial fragments were cut to 5 mm 3 5 mm pieces using a scalpel. Eight pieces of minced endometrial fragments suspended in 0.5 ml PBS were injected into recipients with an 18-gauge needle through the abdominal wall just below the umbilicus into the peritoneal cavity. On the next day of surgery, the mice (n ¼ 5) were intraperitoneally injected with danazol (4 mg/kg body weight), progesterone (5 mg/kg body weight), or MPA (2.5 mg/kg body weight) every day and 16 ll in vivo-jetPEI and 100 lg miR-34a-5p inhibitor (or a control) in 5% glucose every other day for 4 wk, after which all the mice were killed by CO 2 asphyxiation to evaluate the extent of endometriosis. The number of endometriotic lesions was counted with the aid of a dissecting microscope. The diameters of each lesion were measured using the caliper. Lesion volumes calculated using the following formula: lw 2 /2, where l is length and w is width.
Statistical Analysis
Data represent the mean 6 standard deviation unless otherwise indicated. One-way ANOVA followed by Tukey honestly significant difference test was used for comparing differences between multiple groups. Student t-test was used to compare differences between two groups. Statistical significance was set at P , 0.05.
RESULTS
Synthetic Hormone Attenuates Ectopic EN-MSC Proliferation in Both a Time-and Dose-Dependent Manner
To assess the response of EN-MSCs to synthetic steroid hormone drugs, we observed cell proliferation in the presence of danazol, progesterone, MPA, or the control. First, we examined the effect of various concentrations of these drugs (0.1, 1, and 10 lM) and discovered that each inhibited the proliferation of EN-MSCs in a dose-dependent manner after 48 h (Supplemental Fig. S1, A and B, and Fig. 1A) . A time-course study was performed using 1 lM danazol, progesterone, or MPA to assess cell proliferation (Fig. 1B) . Each of the synthetic steroid hormones inhibited EN-MSC proliferation in both a time-and dose-dependent manner. Synthetic steroid hormones are often considered as an antagonist in modulating the effects of estrogen. Therefore, we applied 100 nM estrogen to examine the cell viability by WST-8 assay after 48 h. The data indicated that synthetic steroid hormones affect the cell proliferation in the presence and absence of estrogen. Therefore, this result was interpreted that the effect of synthetic steroids was independent of estrogen action (Fig. 1C) .
It has been reported that synthetic steroid hormones exerting biological effects at the cellular level are mediated by intracellular steroid receptors. Thus, we used Western blot analysis to examine the expression of PGRA, PGRB, and ESR1 after treatment with synthetic steroid hormones for 48 h. We found that the expression of PGRA and ESR1were decreased (about 50%-70%), whereas PGRB was increased in EN-MSCs when treated with synthetic steroid hormones (Fig. 1D ).
Functional Analysis of Upregulated miRNAs by Synthetic Steroid Hormones in Endometriosis
To investigate whether miRNAs are involved in synthetic steroid hormone regulation of EN-MSCs, we selected optimal conditions for miRNA profile array studies. EN-MSCs were treated with 1 lM danazol, progesterone, or MPA, and the miRNA microarrays were analyzed after 48 h of treatment. According to the global miRNA expression profile arrays, we selected candidate miRNAs whose expression changed more than fivefold following the addition of each synthetic steroid hormone. Figure 2A shows the numbers of miRNAs upregulated or downregulated by danazol, progesterone, or MPA. We found 13 miRNAs that were upregulated more than fivefold following synthetic hormone treatment when compared with untreated EN-MSCs (Fig. 2B) . Upregulated miRNAs are listed in Figure 2C . Further, to gain insight into miRNA function or mechanism of action, we subjected them to IPA. The top five diseases, disorders, and molecular and cellular functions predicted by IPA are shown in Figure 2D . The associated diseases and disorders include cancer, connective tissue disorders, organismal injury and abnormalities, reproductive system disease, and inflammatory disease. MiR199a-5p was noted multiple times in the IPA prediction results. The top molecular and cellular functions consist of cell cycle, cell-to-cell signaling and interaction, cellular development, cellular growth and proliferation, and cell death and survival. Among the upregulated miRNAs related to the molecular and cellular functions, miR-34a-5p was noted multiple times in IPA prediction results. In addition, we employed TargetScan Human 6.0 to predict the target genes induced by miR-34a-5p [33] . Supplemental Table S1 shows the classification of predicted target genes for miR-34a-5p based on their cellular function. Figure 2 shows that 13 miRNAs were upregulated following synthetic hormone treatment in EN-MSCs. Therefore, we speculated that miRNAs had reduced expression in EN-MSCs. We used RT-PCR to validate the expression of miRNAs identified in the total population, non-MSCs, and isolated MSCs from the ovarian endometrioma. The lowest expression of miR-34a-5p/miR-199a-5p was found in the isolated MSCs compared with total population and non-MSCs (Fig. 3A) , which prompted us to perform the following experiments using the MSCs.
ENDOMETRIOSIS-SPECIFIC miRNA MODULATION
Validation of miRNA Expression Changes with Synthetic Steroid Hormone Treatment in EN-MSCs
First, we used RT-PCR to confirm the results obtained with the miRNA microarray following synthetic steroid hormone treatment. The levels of miR-34a-5p and miR-199a-5p were increased in EN-MSCs after synthetic steroid hormone treatment (Fig. 3B) . The RT-PCR results for these miRNAs in EN-MSCs were consistent with those of the miRNA profile arrays. In addition, the levels of miR-34a-5p were increased in non-MSCs after synthetic steroid hormone treatment (Supplemental Fig. S1C ).
FIG. 1. WST-8 assay was used to measure cell proliferation. WST-8 assay of cell proliferation in studies of dose dependence (0.1, 1, and 10 lM; A) and a time course (24 and 48 h; B) in EN-MSCs treated with each of three synthetic steroid hormones. Error bars represent the standard deviation for the average of fold change (*P , 0.05). This experiment was repeated three times using different batches of cells. C) Cells were treated with each of three synthetic steroid hormones with and without 100 nM estrogen. After 48 h, the WST-8 assay was used to measure cell proliferation. D) Western blot analysis showed the effects of danazol, progesterone, and MPA on NOTCH1, ESR1, and PGRA/B in EN-MSCs. Band intensity was quantified by ImageJ software.
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Based on the molecular and cellular function predictions using IPA, we further assessed cell proliferation of EN-MSCs following the addition of an inhibitor of miR-34a-5p. We conducted Western blot analysis to evaluate the efficacy of the miR-34a-5p inhibitor on its target expression; we chose 5, 10, and 15 nM inhibitor and treated for 48 h (Fig. 3C) . Optimal results were achieved with 15 nM. Figure 1 shows synthetic steroid hormone attenuation of cell proliferation in EN-MSCs. According to the IPA, miR-34a-5p may play a role related to cell cycle, cell-to-cell signaling, cellular development, cellular growth and proliferation, or cell death and survival (Fig. 2D) . Therefore, we examined the effects of synthetic steroid hormones on the proliferation and cell progression of EN-MSCs and found that the synthetic steroid hormones reduced cell viability of MSCs in treatment groups compared to the untreated control group within the negative control but not the miR inhibitor group (Fig. 3D) . These data indicate that synthetic steroid hormones inhibit EN- A) The levels of miRNA are regulated by synthetic steroid hormones. Thirteen identified miRNAs were simultaneously related to danazol, progesterone, and MPA exposure. B) List of miRNAs that were upregulated more than fivefold by each of the synthetic steroid hormones that were applied ectopically in EN-MSCs. C) IPA revealed predictions for the top diseases and cellular functions for each miRNA. D) The top five different diseases and disorders and molecular and cellular functions associated with the miRNAs of interest are shown.
ENDOMETRIOSIS-SPECIFIC miRNA MODULATION
FIG. 3. Levels of miRNAs in EN-MSCs.
A) Levels of miR-34a-5p and miR-199a-5p in total population, non-MSCs, and isolated MSCs. Data show results from three independent experiments using different batches of cells. B) Expression of miR-34a-5p and miR-199a-5p were significantly higher in the drug treatment group than in the control, as assessed by qPCR (*P , 0.05). Data show results from three independent experiments using different batches of cells. C) Western blot analysis was used to analyze NOTCH1 expression in miR-34a-5p inhibitor-transfected (5, 10, and 15 nM) EN-MSCs and control cells. D) EN-MSCs were treated with synthetic steroid hormones (1 lM danazol, progesterone, or MPA) and inhibitor of miR-34a-5p. The WST-8 assay was used to quantify cell proliferation. E) Analysis revealed the top five different molecular and cellular functions associated with miR-34a-5p target genes. F) Relative level of NOTCH1 in total population, non-MSCs, and isolated MSCs. G) NOTCH1 expression was significantly decreased in the drug treatment HSU ET AL.
MSCs proliferation through induction of miR-34a-5p expression.
To further determine cell cycle progression, we analyzed the effect of synthetic steroid hormones on cell cycle by flow cytometry using EN-MSCs treated with synthetic steroid hormones. The data show that the antiproliferative effect of synthetic steroid hormones on EN-MSCs is mediated by disrupting cell cycle progression, resulting in cell cycle arrest in the G0/G1 phase and inhibition of cell proliferation (Supplemental Fig. S2A ).
Supplemental Table S1 presents predicted miR-34a-5p target genes based on their cellular function. Among these target genes, we found one mutual gene, NOTCH1, which is related to cell cycle, cell-to-cell signaling and interaction, cellular development, cellular growth and proliferation, and cell death and survival (Supplemental Table S1 and Fig. 3E) .
The data in Figure 3C show that NOTCH1 was decreased by miR-34a-5p inhibitor in a dose-dependent manner. Next, we compared the expression levels of NOTCH1 in total population, non-MSCs, and isolated MSCs from the ovarian endometrioma. The expression of NOTCH1 was significantly highest in the isolated MSCs (Fig. 3F ), but its expression decreased after synthetic steroid hormone treatment (Fig. 3G ). In addition, the level of NOTCH1 was decreased in non-MSCs after synthetic steroid hormone treatment (Supplemental Fig.  S1D) . Figure 3 , A and F, shows that miR-34a-5p levels negatively correlated with NOTCH1 expression. To confirm whether the synthetic steroid hormones affect the levels of NOTHC1 via miR-34a-5p in EN-MSCs, we performed a gain and loss study of miR-34a-5p expression under synthetic steroid hormones and miR-34a-5p inhibitor treatments. Figure 3E shows that EN-MSCs transfected with miR-34a-5p inhibitor exhibited increased levels of NOTCH1. The cells treated with synthetic steroid hormones decreased the level of NOTCH1, whereas downregulation of miR-34a-5p rescued the level of NOTCH1 in EN-MSCs (Fig. 3H) . The results, therefore, suggest that synthetic steroid hormones regulate NOTCH1 through miR34a-5p in EN-MSCs.
These data suggested that miR-34a-5p affects NOTCH1 level in EN-MSCs. In a previous study, NOTCH1 was reported to be downregulated by miR-34a, resulting in reduced cancer stemness [34] . Owing to the regenerative traits of endometrial stem/progenitor cells that may actually contribute to endometriosis formation, we carried experiments to study whether synthetic steroid hormones affect the properties of MSCs and to understand the mechanism of synthetic hormone actions on EN-MSCs. We performed RT-PCR to detect the expression of stem cell markers in EN-MSCs by synthetic steroid hormones. We found that synthetic steroid hormones decreased the expression of CD29, CD44, CD90, CD105, and OCT-4, whereas the expressions of stem cell markers were reversible at 24 h following synthetic steroid hormones withdrawal (Supplemental Fig. S2B ). Therefore, we hypothesized that synthetic steroid hormones may regulate certain genes and then modulate the characteristics of EN-MSCs.
We also analyzed the effect of synthetic steroid hormones on the cell cycle, and the results showed that synthetic steroid hormones induce G0/G1 arrest (Supplemental Figure S2A) . Thus, the WST-8 assay was used to test whether the cell proliferation by synthetic steroid hormones was transient. ENMSCs were treated with synthetic steroid hormones for 48 h, and then the degree of cell proliferation after 24 h removal of synthetic steroid hormones was determined. The data indicate that cell proliferation was rescued after removal of synthetic steroid hormones (Supplemental Fig. S2C ). Taken together, the synthetic steroid hormones did not affect terminal differentiation of MSCs, and repressed proliferation was transiently in our study. Therefore, we hypothesized that the effects of synthetic steroid hormones on EN-MSCs were reversible (Supplemental Fig. S2, B and C) .
Synthetic Steroid Hormones Regulates the Expression of miR-34a-5p and Notch1 In Vivo
In vitro, we demonstrated that synthetic steroid hormones inhibited proliferation and regulated the level of miRNAs in EN-MSCs. Next, we asked whether synthetic steroid hormone affect endometriotic lesion formation and the level of Notch1 through miR-34a-5p in vivo. Endometriosis was induced in mice as reported previously [32] .
After 28 days of synthetic steroid hormones or miR-34a-5p inhibitor treatment, we found that the endometriotic lesion sizes of the synthetic steroid hormone treatment group were smaller than those in the control. The lesion sizes of miR-34a-5p inhibitor and synthetic steroid hormone treatment group were smaller than those in the miR-34a-5p inhibitor group (Fig.  4A) . The degree of successful implantation and the size of the endometriotic lesions in the mice are shown in Table 1 . Hematoxylin and eosin staining of the lesions in the controls showed a typical endometrial appearance, with endometrial glandular epithelium and stromal cells (Fig. 4B) . In contrast, the lesions of the treatment group lacked the typical glandular structure organization. We evaluated the levels of miR-34a-5p in the animal model of endometriotic lesion. The levels of miR34a-5p were increased by synthetic steroid hormone treatment, whereas Notch1 expression was decreased. In contrast, the mice transfected with miR-34a-5p inhibitor exhibited increased levels of Notch1, whereas synthetic steroid hormone treatment decreased the levels of Notch1 (Fig. 4, C and D) . Our in vivo study showed that the levels of miRNAs in endometriotic lesions correlated with the in vitro data following synthetic hormone treatment. The in vitro and in vivo data thus supported the assumption that the synthetic steroid hormones we administered upregulated miR-34a-5p and downregulated Notch1.
DISCUSSION
Danazol, progesterone, and MPA have been used to treat patients with endometriosis to attenuate symptoms and shrink the resulting lesions. The steroid hormone is the key regulator in the endometriosis growth, and its use in the treatment of endometriosis is based on depressing the output of folliclestimulating hormone, luteinizing hormone, or estrogen produced by the ovaries. Progesterone resistance is a hallmark of endometriosis, and endometriotic tissues are still considered estrogen responsive. Differential expression of ESR1 and PGRA/B in ovarian endometrioma is considered to reflect their response to ovarian steroid action [35] . Although the in vitro condition does not reflect the complex in vivo condition, in this study, we present evidence that the synthetic steroid hormones affect ESR1 and PGRA/B expression.
The miRNAs within endometrial stem cells play important roles in endometriosis progression [2, 36] . We previously showed that miR-199a-5p helps to regulate endometriosis progression in EN-MSCs [9] . However, the effects of synthetic steroid hormones on miRNAs and their subsequent effects on endometrial stem cells were unclear. Our present study reveals that the addition of specific synthetic steroid hormones can modulate miRNA levels in EN-MSCs, subsequently causing a change in endometriotic tissue in an animal model. Several studies have shown that specific miRNAs may regulate the inflammatory response, embryonic implantation [37] , and differentiation [38] . Among these miRNAs, miR199a-5p, miR-299a-3p, and miR-346 have been reported to be associated with inflammation; furthermore, miR-199a-5p was reported to be related to ovarian cancer [39] [40] [41] . In addition, several studies have shown that specific steroid hormones may regulate the inflammatory response [42, 43] .
Pan et al. [44] and Dai et al. [45] have shown that miR199a-5p is downregulated in ectopic endometrial tissue compared with normal controls. Several studies have also shown that miR-199a-5p targets multiple genes and modulates tumor progression and cell invasion [39, 45] . In addition, we have reported important aspects of miR-199a-5p function in endometriosis, including angiogenesis and cell motility [9] . In the present study, we focused on miR-34a-5p, which, by IPA, is predicted to function during the cell cycle, cell-to-cell signaling and interaction, cellular development, cellular growth/ proliferation, and cell death/survival.
MiR-34a is known as a tumor-suppressor miRNA. Several studies have reported that miR-34a can target a variety of genes involved in tumor progression, such as C-MET, E2F, and SNAIL, and is dysregulated in many cancer types, such as glioblastoma, endometrial carcinoma, and ovarian cancer [22, [46] [47] [48] [49] . MiR-34a affects cell cycle arrest by downregulating E2F, CCND1, and CDK6 [50, 51] . It has been reported that miR-34a is associated with regulation of cancer stem cells function in various cancer types such as glioblastoma and prostate cancer [52, 53] . Repression of C-KIT mediated by miR-34a was associated with reduced chemoresistance, migration, and stemness in colon cancer [54] . Interestingly, one of the miR-34a target genes, namely NOTCH1, is a stem cell-associated gene and important in cancer progression. It is involved in the regulation of self-renewal, differentiation, and survival of cancer stem cells [55, 56] . NOTCH1 reportedly is also downregulated by miR-34a, resulting in reduced cancer stemness and chemoresistance in breast cancer [34] . Additionally, aberrant stem cell function has been implicated in endometriosis progression. Supplemental Figure S1 shows that the synthetic steroid hormones affect the properties of stem cells. Therefore, we speculate that synthetic steroid hormones may contribute to regulate stemness in endometriotic stemprogenitor cells through the miR-34a-NOTCH1 interaction in disordered endometrial cells. Moreover, miR-34a inhibits the NOTCH1 level by binding the 3 0 untranslated region of its mRNA, thereby targeting the mRNA for degradation [22, 57] . Although the in vitro condition does not reflect the complex in vivo situation, these results imply that miR-34a is hormonally regulated in endometriosis, potentially influencing the expression of genes targeted by miR-34a.
In the present study, we demonstrate that specific synthetic steroid hormones upregulate miR-34a-5p in endometriotic cells. Further study is needed to identify the upstream regulator of miR-34a-5p affected by the synthetic steroid hormones. In this study, we also show that danazol can upregulate miR199a-5p level in EN-MSCs. Our previous study demonstrated that SMAD4, which is a tumor suppressor gene, elevates the level of miR-199a-5p expression and inhibits proliferation and angiogenesis in EN-MSCs [9] . Those findings point to the possibility that ectopic danazol might inhibit proliferation and angiogenesis in EN-MSCs and that the SMAD4-miR-199a-5p pathway may be the target of danazol action. It thus may be informative to investigate this potential mechanism related to the steroid hormonal effects on miRNAs.
Our results show a strong relationship between synthetic steroid hormonal action and subsequent downstream effects on miRNA levels in ovarian endometrioma. Further studies are necessary to understand the molecular mechanism related to the steroid hormone-based stimulation of miRNAs and the subsequent regulation of the signaling pathway in endometriosis.
